Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,414 | -32,084 | -9,390 | -5,746 | -2,421 |
| Depreciation Amortization | 1,301 | 759 | 502 | 311 | 123 |
| Accounts receivable | 636 | 140 | -1,031 | 412 | -534 |
| Other Working Capital | 2,050 | 986 | 262 | 291 | 159 |
| Other Operating Activity | 2,412 | 19,750 | 4,566 | 1,526 | 924 |
| Operating Cash Flow | $-16,015 | $-10,449 | $-5,091 | $-3,206 | $-1,749 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -175 | N/A | -47 | N/A | N/A |
| PPE Investments | -3,370 | -2,324 | -842 | -844 | -1,291 |
| Other Investing Activity | -156 | -114 | -91 | -59 | -45 |
| Investing Cash Flow | $-3,701 | $-2,438 | $-980 | $-903 | $-1,336 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 800 |
| Debt Repayment | N/A | N/A | N/A | -1,000 | N/A |
| Common Stock Issued | -51 | 58,670 | 16,367 | 8,373 | 2,546 |
| Other Financing Activity | 0 | -104 | 341 | 0 | -45 |
| Financing Cash Flow | $-51 | $58,566 | $16,708 | $7,373 | $3,301 |
| Exchange Rate Effect | 550 | 756 | N/A | N/A | N/A |
| Beginning Cash Position | 61,813 | 15,378 | 4,741 | 1,477 | 1,261 |
| End Cash Position | 42,596 | 61,813 | 15,378 | 4,741 | 1,477 |
| Net Cash Flow | $-19,217 | $46,435 | $10,637 | $3,264 | $216 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,015 | -10,449 | -5,091 | -3,206 | -1,749 |
| Capital Expenditure | -3,371 | -2,335 | -842 | -844 | -1,291 |
| Free Cash Flow | -19,386 | -12,784 | -5,933 | -4,050 | -3,040 |